VivoSim Labs, Inc.
VIVS · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $2 |
| % Growth | 32.1% | -70.5% | -75.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $2 |
| % Margin | 96.5% | 100% | 100% | 100% |
| R&D Expenses | $5 | $5 | $9 | $3 |
| G&A Expenses | $8 | $10 | $9 | $10 |
| SG&A Expenses | $8 | $10 | $9 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $13 | $15 | $18 | $13 |
| Operating Income | -$13 | -$15 | -$18 | -$11 |
| % Margin | -8,761.1% | -13,840.4% | -4,792.2% | -765.3% |
| Other Income/Exp. Net | $10 | $0 | $0 | $0 |
| Pre-Tax Income | -$2 | -$15 | -$17 | -$11 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$15 | -$17 | -$11 |
| % Margin | -1,727.8% | -13,459.6% | -4,664.6% | -763.2% |
| EPS | -1.7 | -19.25 | -23.76 | -15.84 |
| % Growth | 91.2% | 19% | -50% | – |
| EPS Diluted | -1.7 | -19.25 | -23.76 | -15.84 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$15 | -$17 | -$11 |
| % Margin | -1,534.7% | -13,583.5% | -4,713% | -755.8% |